NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
AIVIVA BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
72
Latest update
02/17/2026
Trademark type
Combined
Nice classes
5
Filing date
05/20/2020
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/06/2024
First use in commerce
05/06/2024
Drawing code
5
Owner type
03
Owner location
Dover, DE, US
Examiner
JANSON, ANDREW KYLE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "AIVIVA" having an extended downward line on the first letter "A" and a an extended upward line on the first "V" above the word "BioPharma".
Holders and representatives
Holders
AiViva Biopharma, Inc.
Representatives
JOE MCKINNEY MUNCY MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-dermoinfectives; Anti-friction skin preparations for preventing blisters; Anti-friction skin preparations for preventing chafing; Antibacterial alcohol skin sanitizer gel; Antimicrobials for dermatologic use; Bandages for skin wounds; Dermatological pharmaceutical products; Gelscreams and solutions for dermatological use; Medical cleansers for skin and wounds; Medical preparationsfoothand and skin creams for diabetics; Medicaments for treating skin disorderscancer and prostate related disorder; Medicated balms for treatment of skin; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated lotions for skin; Medicated ointments for treating dermatological conditions; Medicated skin preparation for use in treating aberrant wound healing and skin cancer; Non-medicatedtherapeutic skin creams for the treatment of aberrant wound healing and skin cancer; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for skin care for animals; Preparations for cleansing the skin for medical use; Processed human donor skin for the replacement of soft tissue; Skin grafts; Topical dermatological preparations that treat insect bites and stings
Publications
History of USPTO decisions and trademark events.
72 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/26/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/26/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2026
ALIE
ASSIGNED TO LIE
01/24/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/20/2025
GNRT
NON-FINAL ACTION E-MAILED
11/20/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/20/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/20/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/13/2025
IUAF
USE AMENDMENT FILED
09/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/16/2025
EX5G
SOU EXTENSION 5 GRANTED
09/16/2025
EXT5
SOU EXTENSION 5 FILED
04/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/16/2024
EX4G
SOU EXTENSION 4 GRANTED
09/16/2024
EXT4
SOU EXTENSION 4 FILED
09/16/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2024
EX3G
SOU EXTENSION 3 GRANTED
03/29/2024
EXT3
SOU EXTENSION 3 FILED
03/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/29/2024
IULN
ITU LETTER MAILED, NO RESPONSE REQUIRED
10/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/30/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/29/2023
EX2G
SOU EXTENSION 2 GRANTED
09/28/2023
EXT2
SOU EXTENSION 2 FILED
09/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2023
EX1G
SOU EXTENSION 1 GRANTED
01/09/2023
EXT1
SOU EXTENSION 1 FILED
01/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2023
DOCK
ASSIGNED TO EXAMINER
12/13/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/04/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/21/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/09/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/09/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/09/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2021
GNRT
NON-FINAL ACTION E-MAILED
09/27/2021
CNRT
NON-FINAL ACTION WRITTEN
09/27/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/23/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
12/03/2020
CNSL
SUSPENSION LETTER WRITTEN
12/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2020
GNRT
NON-FINAL ACTION E-MAILED
08/20/2020
CNRT
NON-FINAL ACTION WRITTEN
08/20/2020
DOCK
ASSIGNED TO EXAMINER
08/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/04/2020
NWAP
NEW APPLICATION ENTERED
05/23/2020
Continuous trademark protection
Get notified about every new filing that threatens AIVIVA BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.